Search PubMed⌕ Search

Biomedical subjects

A Dufour

Publications and source records attributed to A Dufour.

At least 91 records · Page 5Linked to original sources
PubMed1983

Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.

The kinetics of cibenzoline (UP 339.01), a new antiarrhythmic drug, was studied after i.v. and oral administration to 5 healthy subjects. Cibenzoline levels in plasma and urine cibenzoline were measured by a GLC method. After i.v. administration, the total clearance was 826 ml . min-1. The fraction of cibenzoline excreted unchanged in the urine was 0.602 and it was correlated with the creatinine clearance. After i.v. and oral administration, the renal clearances were 499 ml . min-1 and 439 ml . min-1, and the half-lives were 4 h 01 min and 3 h 24 min, respectively. The differences were not significant. Availability by the oral route was 0.92, the maximum plasma concentration being observed at 1 h 36 min. The results were compared with those for other antiarrhythmic drugs.

Administration, Oral↗
PubMed1983

The pharmacokinetics and availability of niflumic acid in humans.

The pharmacokinetic parameters and relative availability of niflumic acid in two different pharmaceutical preparations were studied in 12 subjects after a single oral administration. Total plasma clearance averaged 45 ml/min, and the half-life of elimination approximately 2 h, giving a distribution volume of 0.12 l/kg on the average. The values of these pharmacokinetic parameters were in agreement with the general characteristics of this type of substance, a weak acid strongly bound to plasma proteins. Comparison of the systemic availability of the two oral forms showed no difference; they were probably close to 100%.

Absorption↗
PubMed1980

[Heavy haematuria as the presentation of attenuated haemophilia B (author's transl)].

The authors report a rare case of eosinophilic cystitis presenting with heavy haematuria which led to the discovery of attenuated haemophilia B. Bleeding and clotting times in this patient, with no past history of haemorrhage, were normal. Complete coagulation studies led to the diagnosis in the presence of poor plasma prothrombin consumption and a moderate deficit in clotting factor IX, defining haemophilia B. Despite two partial cystectomies for haemorrhagic lesions of the dome of the bladder (eosinophilic cystitis), carried out with transfusion cover and the administration of P.P.S.B., recurrence of haematuria made it necessary to "rest" the bladder by a cutaneous ureterostomy. Subsequently, the restoration of urinary continuity was possible by uretero-ileo-cystoplasty, without any haemorrhagic complications by virtue of the use of P.P.S.B. The value of the association of epsilon amino-caproic acid with P.P.S.B. is emphasised in the prevention of haemorrhagic complications during surgery in haemokphilia B patients. In attenuated forms of haemophilia B (factor IX level between 5 and 15%) haemorrhages may be only occasional and occur only late in life.

Adult↗
PubMed1978

[Not Available].

Explore the source record for details and available documents.

History, Modern 1601-↗
PubMed1977

The effect of oxidase positive bacteria on total coliform density estimates.

The most probable number method for enumerating coliforms was shown to give a false estimate of the coliform density. The inflated estimates were due to lactose positive, non-coliform bacteria whose presence was detected by an oxidase test. Thirty-six percent of all the samples examined contained oxidase positive bacteria that were able to produce gas from lactose. Their presence resulted in coliform density overestimates which ranged from 2 to 33 times the true value. The frequency of occurrence of inaccurate estimates was shown to be affected by water temperature but unrelated to environmental source.

Aeromonas↗